Australia, Dec. 23 -- Scholar Rock Inc., owns the trademark (2553980) for 'ISEMBYLD' till March 31, 2033.
Status: protected:
Registered/protected
Class: 5 [Monoclonal antibodies for medical purposes; antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprised of apitegromab; therapeutic agents and pharmaceutical preparations for the diagnosis, treatment, and prevention of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders.]
Type of Mark: Word
Date of Acceptance: July 21
Registration Advertised: Dec. 22
For further details contact Greenfield & Sacks P.C. Douglas R. Wolf Wolf.
The original document can be viewed a...